Due Diligence

Expanding Into Asia-Pacific: Life sciences opportunities and strategies for success
Objective :

A mid pharma client, headquartered in Germany, wanted to have a level of confidence on their soon-to-be partner for manufacturing of their therapeutics.

Problem Statement:

A medium pharmaceutical client with capabilities in novel formulations was involved in a deal with a manufacturing company for commercial-scale manufacturing of the client’s therapies. The client involved DelveInsight to conduct a comprehensive appraisal of the partner’s business, prior to the closing of the deal between the two parties.

Our Methodology:
  • Manufacturing Capability Assessment through Site and Equipment Analysis
  • Financial Assessment through review of Quarterly and Annual Financial reports
  • Intellectual Property Assessment through Patent Assessment
  • Primary Analysis to establish references for the partner company’s credibility
Results:
  • Detailed Assessment Outcome of the capabilities and stability of the Partner Company
  • Analysis provided relating to the strength of the intellectual property of the Partner Company
  • References provided to support Due Diligence output
  • Analyst Comments on suitability of Partnership

Related Insights

Product Assessment
Product Assessment

A large pharma client was working to develop their cyclophosphamide API and FD, and was interested to assess competitive products [...]

View Case
Asset Prioritization
Asset Prioritization

A mid-sized pharma client was working to develop their asset portfolio, and was interested to assess best possible asset for atrial fibrillation [...]

View Case
Competitive Intelligence
Competitive Intelligence

A large client based in Europe involved DelveInsight to assist in assessing counter-intelligence strategies for them, after evaluation of their level of leakiness among middle and high-level employees. [...]

View Case

Fill the form to download the case study

I consent to DelveInsight gathering details provided via this form. Check our Privacy Policy to know more.